182 related articles for article (PubMed ID: 10385693)
21. Effects of bisphosphonates on human esophageal squamous cell carcinoma cell survival.
Minegaki T; Fukushima S; Morioka C; Takanashi H; Uno J; Tsuji S; Yamamoto S; Watanabe A; Tsujimoto M; Nishiguchi K
Dis Esophagus; 2016 Aug; 29(6):656-62. PubMed ID: 25894100
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
Dunford JE; Rogers MJ; Ebetino FH; Phipps RJ; Coxon FP
J Bone Miner Res; 2006 May; 21(5):684-94. PubMed ID: 16734383
[TBL] [Abstract][Full Text] [Related]
23. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
Mönkkönen H; Auriola S; Lehenkari P; Kellinsalmi M; Hassinen IE; Vepsäläinen J; Mönkkönen J
Br J Pharmacol; 2006 Feb; 147(4):437-45. PubMed ID: 16402039
[TBL] [Abstract][Full Text] [Related]
24. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.
Luckman SP; Coxon FP; Ebetino FH; Russell RG; Rogers MJ
J Bone Miner Res; 1998 Nov; 13(11):1668-78. PubMed ID: 9797474
[TBL] [Abstract][Full Text] [Related]
25. Biochemical and molecular mechanisms of action of bisphosphonates.
Rogers MJ; Crockett JC; Coxon FP; Mönkkönen J
Bone; 2011 Jul; 49(1):34-41. PubMed ID: 21111853
[TBL] [Abstract][Full Text] [Related]
26. The relationship between the chemistry and biological activity of the bisphosphonates.
Ebetino FH; Hogan AM; Sun S; Tsoumpra MK; Duan X; Triffitt JT; Kwaasi AA; Dunford JE; Barnett BL; Oppermann U; Lundy MW; Boyde A; Kashemirov BA; McKenna CE; Russell RG
Bone; 2011 Jul; 49(1):20-33. PubMed ID: 21497677
[TBL] [Abstract][Full Text] [Related]
27. Efficient use of exogenous isoprenols for protein isoprenylation by MDA-MB-231 cells is regulated independently of the mevalonate pathway.
Onono F; Subramanian T; Sunkara M; Subramanian KL; Spielmann HP; Morris AJ
J Biol Chem; 2013 Sep; 288(38):27444-27455. PubMed ID: 23908355
[TBL] [Abstract][Full Text] [Related]
28. Zoledronic acid induces apoptosis and S-phase arrest in mesothelioma through inhibiting Rab family proteins and topoisomerase II actions.
Okamoto S; Jiang Y; Kawamura K; Shingyoji M; Tada Y; Sekine I; Takiguchi Y; Tatsumi K; Kobayashi H; Shimada H; Hiroshima K; Tagawa M
Cell Death Dis; 2014 Nov; 5(11):e1517. PubMed ID: 25393473
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
[TBL] [Abstract][Full Text] [Related]
30. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
[TBL] [Abstract][Full Text] [Related]
31. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells.
Miquel K; Pradines A; Tercé F; Selmi S; Favre G
J Biol Chem; 1998 Oct; 273(40):26179-86. PubMed ID: 9748300
[TBL] [Abstract][Full Text] [Related]
32. Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
Virtanen SS; Väänänen HK; Härkönen PL; Lakkakorpi PT
Cancer Res; 2002 May; 62(9):2708-14. PubMed ID: 11980672
[TBL] [Abstract][Full Text] [Related]
33. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Räikkönen J; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Pharmacol; 2010 Mar; 79(5):777-83. PubMed ID: 19819230
[TBL] [Abstract][Full Text] [Related]
34. Isoprenoid alcohols restore protein isoprenylation in a time-dependent manner independent of protein synthesis.
Ownby SE; Hohl RJ
Lipids; 2003 Jul; 38(7):751-9. PubMed ID: 14506838
[TBL] [Abstract][Full Text] [Related]
35. Lovastatin induces apoptosis by inhibiting mitotic and post-mitotic events in cultured mesangial cells.
Ghosh PM; Mott GE; Ghosh-Choudhury N; Radnik RA; Stapleton ML; Ghidoni JJ; Kreisberg JI
Biochim Biophys Acta; 1997 Oct; 1359(1):13-24. PubMed ID: 9398081
[TBL] [Abstract][Full Text] [Related]
36. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
Frith JC; Mönkkönen J; Auriola S; Mönkkönen H; Rogers MJ
Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
[TBL] [Abstract][Full Text] [Related]
37. Nitrogen-containing bisphosphonates induce S-phase cell cycle arrest and apoptosis of myeloma cells by activating MAPK pathway and inhibiting mevalonate pathway.
Iguchi T; Miyakawa Y; Yamamoto K; Kizaki M; Ikeda Y
Cell Signal; 2003 Jul; 15(7):719-27. PubMed ID: 12742232
[TBL] [Abstract][Full Text] [Related]
38. Physiology of the aging bone and mechanisms of action of bisphosphonates.
Dominguez LJ; Di Bella G; Belvedere M; Barbagallo M
Biogerontology; 2011 Oct; 12(5):397-408. PubMed ID: 21695491
[TBL] [Abstract][Full Text] [Related]
39. Bisphosphonates: mode of action and pharmacology.
Russell RG
Pediatrics; 2007 Mar; 119 Suppl 2():S150-62. PubMed ID: 17332236
[TBL] [Abstract][Full Text] [Related]
40. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
